Turtle Creek Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
2,732
+52
+2% +$25K 0.07% 140
2026
Q1
$1.32M Buy
2,680
+718
+37% +$390K 0.1% 127
2025
Q4
$1.14M Buy
1,962
+173
+10% +$97.8K 0.09% 138
2025
Q3
$868K Buy
1,789
+602
+51% +$280K 0.08% 146
2025
Q2
$481K Buy
+1,187
New +$496K 0.06% 171
2024
Q4
Sell
-921
Closed -$570K 154
2024
Q3
$570K Buy
921
+62
+7% +$36.7K 0.11% 94
2024
Q2
$475K Buy
859
+128
+18% +$73.3K 0.11% 92
2024
Q1
$425K Buy
731
+23
+3% +$12.9K 0.1% 98
2023
Q4
$376K Buy
+708
New +$343K 0.11% 108

Other funds holding TMO

Turtle Creek Wealth Advisors's TMO Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, buying an estimated $25K and bringing the position to 2,732 shares worth $1.37M. The position accounts for 0.07% of the portfolio, ranked #140.

Turtle Creek Wealth Advisors first reported a position in TMO in Q4 2023 and has held it in 9 quarters since. 1,289 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Turtle Creek Wealth Advisors held 2,732 shares of Thermo Fisher Scientific worth $1.37M as of Q2 2026.
  • Turtle Creek Wealth Advisors bought 52 Thermo Fisher Scientific shares in Q2 2026, an estimated $25K.
  • Thermo Fisher Scientific made up 0.07% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #140 holding.
  • Turtle Creek Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 9 quarters since.
  • 1,289 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.